Home Cart Sign in  
Chemical Structure| 1621175-65-2 Chemical Structure| 1621175-65-2

Structure of TC-G-1008
CAS No.: 1621175-65-2

Chemical Structure| 1621175-65-2

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

TC-G 1008 is a selective GPR39 agonist with EC50 value of 0.8 nM.

Synonyms: GPR39-C3

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of TC-G-1008

CAS No. :1621175-65-2
Formula : C18H19ClN6O2S
M.W : 418.90
SMILES Code : CS(=O)(NC1=CC=C(CNC2=NC(NC)=NC(C3=NC=CC=C3)=C2)C(Cl)=C1)=O
Synonyms :
GPR39-C3
MDL No. :MFCD30182283
InChI Key :DRSZMILOMUPIBJ-UHFFFAOYSA-N
Pubchem ID :91826086

Safety of TC-G-1008

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P280-P301+P312-P302+P352-P305+P351+P338

Related Pathways of TC-G-1008

GPCR

Isoform Comparison

Biological Activity

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice (Swiss Albino and C57BL/6/Tar × CBA/Tar) PTZ-induced kindling model of epilepsy Intraperitoneal injection 10 mg/kg Once daily on alternate days during weekdays for 19 injections (Swiss Albino) or 14 injections (C57BL/6/Tar × CBA/Tar) TC-G 1008 facilitated PTZ-epileptogenesis by acting selectively at GPR39 but markedly increased the activation of CREB in the hippocampus of GPR39 KO mice, suggesting non-selectivity Cell Mol Life Sci. 2023 Apr 25;80(5):133
CD-1 male mice Forced swim test (FST) Intraperitoneally 10 or 15 mg/kg Single or chronic administration TC-G 1008 at a dose of 15 mg/kg significantly decreased immobility time in the forced swim test, indicating an antidepressant-like effect. Pharmacol Rep. 2023 Jun;75(3):609-622
Female Wistar rats Corticosterone-induced depression and overactive bladder model Intraperitoneal injection 15 mg/kg/day Once daily for 7 days TC-G 1008 alleviated corticosterone-induced depression-like behavior and overactive bladder symptoms, restoring biochemical and cystometric markers to normal levels. Int J Mol Sci. 2024 Nov 25;25(23):12630
Mice Epilepsy models Intraperitoneal injection 2.5, 5, 10, 20, 40 mg/kg 30 min pretreatment TC-G 1008 decreased the seizure threshold in the MEST test, while it increased the seizure threshold in the 6-hertz-induced seizure threshold test. In the PTZ kindling model, TC-G 1008 aggravated epileptogenesis. Cells. 2022 Jun 21;11(13):1987
Sprague Dawley rats Neonatal hypoxic-ischemic encephalopathy (HIE) model Intranasal administration 5 mg/kg, 15 mg/kg, 45 mg/kg Administered at 1 h, 25 h, 49 h, and 73 h post-HIE induction TC-G 1008 attenuated neuroinflammation via the SIRT1/PGC-1α/Nrf2 pathway, improving short-term and long-term neurological deficits J Neuroinflammation. 2021 Oct 13;18(1):226
Male Swiss Albino mice Maximal electroshock seizure threshold (MEST) test and pentylenetetrazole (PTZ)-kindling model of epilepsy Intraperitoneal injection 5, 10, 20 mg/kg Single administration (MEST test) or repeated administration (PTZ-kindling model, every alternate day for 13 injections) TC-G-1008 decreased the seizure threshold in the MEST test in mice fed the ZnD diet but not in mice fed the ZnA diet. In the PTZ-kindling model, TC-G-1008 increased the maximal seizure severity and the percentage of fully kindled mice in those fed the ZnA diet, but not in mice fed the ZnD diet. Cells. 2023 Jan 9;12(2):264
Sprague-Dawley rats Spared nerve injury-induced neuropathic pain model Intrathecal injection 5, 20, or 50 μg Single injection or continuous injection for 5 days TC-G 1008 significantly alleviated mechanical allodynia in rats with spared nerve injury, improved spinal cord mitochondrial biogenesis, and alleviated neuroinflammation. Neural Regen Res. 2024 Mar;19(3):687-696
Mice Traumatic stress-enhanced drinking model Intraperitoneal injection 5, 7.5, 10 mg/kg 30 min pretreatment time TC-G significantly suppressed binge drinking in male and female mice in the control studies, but female mice were insensitive to TC-G in the traumatic stress drinking model. Alcohol Clin Exp Res (Hoboken). 2025 Apr;49(4):866-882
Mice Drinking model Intraperitoneal injection 7.5 mg/kg Acute administration Reduced ethanol intake Neuropsychopharmacology. 2019 May;44(6):1103-1113

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.39mL

0.48mL

0.24mL

11.94mL

2.39mL

1.19mL

23.87mL

4.77mL

2.39mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories